ClearBridge Investments’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.64M Sell
202,815
-6,468
-3% -$211K 0.01% 498
2025
Q4
$6.3M Sell
209,283
-73,567
-26% -$2.08M 0.01% 553
2025
Q3
$7.42M Sell
282,850
-162,674
-37% -$3.88M 0.01% 549
2025
Q2
$9.49M Sell
445,524
-65,316
-13% -$1.47M 0.01% 483
2025
Q1
$10.9M Sell
510,840
-149,810
-23% -$3.07M 0.01% 479
2024
Q4
$13.4M Sell
660,650
-3,760
-0.6% -$77.6K 0.01% 493
2024
Q3
$11.2M Buy
+664,410
New +$11.2M 0.01% 522

Other funds holding GRDN

ClearBridge Investments's GRDN Position: Q1 2026 in Review

ClearBridge Investments reduced its Guardian Pharmacy Services (GRDN) stake by 3.1% in Q1 2026, selling an estimated $211K and leaving 202,815 shares worth $7.64M. The position accounts for 0.01% of the portfolio, ranked #498.

ClearBridge Investments first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.4M in Q4 2024. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • ClearBridge Investments held 202,815 shares of Guardian Pharmacy Services worth $7.64M as of Q1 2026.
  • ClearBridge Investments sold 6,468 Guardian Pharmacy Services shares in Q1 2026, an estimated $211K.
  • Guardian Pharmacy Services made up 0.01% of ClearBridge Investments's portfolio in Q1 2026, its #498 holding.
  • ClearBridge Investments first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • ClearBridge Investments's Guardian Pharmacy Services position peaked at $13.4M in Q4 2024.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on ClearBridge Investments's 13F filing for Q1 2026, filed 13 May 2026.